Fei Ye, Ying Zhao, Ramy El-Sayed, Mamoun Muhammed, Moustapha Hassan
文献索引:10.1016/j.nantod.2017.12.008
全文:HTML全文
Cancer biomarkers with high selectivity, specificity and reproducibility play essential role in diagnosis, prognosis and prediction of treatment efficacy in cancer patients. However, the current biomarker assays used in clinics could be improved due to low sensitivity and specificity. Nanoparticle-based assays are emerging as an upcoming approach, providing ultra-high sensitivity and specificity in cancer biomarker detection. The current survey presents an overview of strategies used in the development and integration of nanoparticles for cancer biomarker detection, including mass spectrometry, optical and electrical detection methods. Moreover, we discuss the future trends in the field in correlation to new approaches from fundamental and practical standpoints.
Recent advances in functional nanomaterials for light–trigge...
2018-03-13 [10.1016/j.nantod.2018.02.010] |
Recent progress on the photocatalysis of carbon dots: Classi...
2018-03-12 [10.1016/j.nantod.2018.02.008] |
Colloidal aggregation: From screening nuisance to formulatio...
2018-03-10 [10.1016/j.nantod.2018.02.011] |
Two-dimensional transition metal dichalcogenide hybrid mater...
2018-03-07 [10.1016/j.nantod.2018.02.007] |
Guiding Rules for Selecting a Nanothermometer
2018-03-07 [10.1016/j.nantod.2018.02.012] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved